Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GH Research PLC - Ordinary Shares (NQ:GHRS)

15.33 +0.17 (+1.12%)
Streaming Delayed Price Updated: 11:00 AM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GH Research PLC - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Why Is GHRS Stock Rising Today? ↗
GH Research stated that the FDA has cleared GH001 for a clinical investigation in the U.S. 
Via Stocktwits
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment ↗
GH001 showed symptom improvement, high remission rates, and sustained benefits in a Phase 2b trial for treatment-resistant depression. 
Via Stocktwits
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
GH Research to Announce IND Status for GH001
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research PLC (NASDAQ:GHRS) Reports Q3 2025 Earnings Beat and Clinical Progress ↗
GH Research Q3 2025 results show a slight EPS beat. The biotech firm is focused on resolving the FDA clinical hold for its GH001 treatment for depression. 
Via Chartmill
Topics Earnings
News headline image
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
News headline image
Depression-Focused GH Research Shares Could See Significant Upside: Analyst ↗
GH Research's GH001 shows strong Phase 2 results for treatment-resistant depression, with FDA issues nearly resolved and $1.9 billion U.S. potential. 
Via Benzinga
News headline image
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
GH Research Announces Global Pivotal Program Plans and Further Development Updates
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
News headline image
JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
GH Research Reports Full Year 2024 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
News headline image
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week ↗
These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments. 
Via Stocktwits
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill
News headline image
These stocks have an unusual volume in today's session ↗
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
News headline image
GH Research Announces Pricing of $150 Million Public Offering
From GH Research PLC
Via GlobeNewswire
News headline image
Unusual volume stocks in Tuesday's session ↗
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
News headline image
GH Research Announces Proposed Public Offering
From GH Research PLC
Via GlobeNewswire
News headline image
Crude Oil Moves Higher; Owens & Minor Shares Plummet ↗
 
Via Benzinga
News headline image
Dow Falls 150 Points; ISM Manufacturing PMI Rises In January ↗
 
Via Benzinga
Topics Stocks
News headline image
IDEXX Laboratories Posts Upbeat Results, Joins Stratasys, Saia And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.